製薬用膜ろ過市場 : 2029年までの世界予測

Report Overview

The global pharmaceutical membrane filtration market is projected to reach USD 19.6 billion by 2029 from USD 10.6 billion in 2024, at a CAGR of 13.1% during the forecast period of 2024 to 2029.

世界の製薬用膜ろ過市場は、2024年から2029年の予測期間中に13.1%のCAGRで、2024年の106億ドルから2029年までに196億ドルに達すると予測されています。

The growth of this market can be attributed to increasing purity requirements in end-use industries. In the life sciences industry, ultrapure water is essential for genomics, proteomics, immunology, pharmacology, cell and tissue culture, and drug discovery. Due to the increasing demand for Type I, ultrapure, or research-grade water in life science research, pure lab water supply has become one of the most important and fastest-growing markets in the laboratory industry. This trend is expected to drive the growth of the pharmaceutical membrane filtration market in the coming years.

 “The sterile filtration segment accounted for the largest share by type in 2023.”
In 2023, the sterile filtration segment accounted for the largest share by type in the global pharmaceutical membrane filtration market. Sterile filtration is the process of microbial removal and plays an important role in assuring final product sterility. Sterile filters are widely used for the intermediate and final filtration of liquid drug products. According to regulatory authorities, sterile-grade filters are required for the final product processing of drugs and are of utmost importance during final product processing. Moreover, there are various advantages of sterile filters over non-sterile filters, which make them the preferred choice for upstream and downstream processing in the pharmaceutical and biopharmaceutical industries.

 “The US has continued to dominate the pharmaceutical membrane filtration market during the forecast period of 2024-2029.”
The US dominated the pharmaceutical membrane filtration market in North America in 2023. The US is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research/investments. Additionally, the US is home to some of the world’s leading academic research institutes, including Harvard University, Stanford University, and the Massachusetts Institute of Technology (MIT). These institutes conduct cutting-edge research in life sciences, including drug discovery, genomics, and biotechnology, which require the use of membrane filtration products. Technological advancements in filtration membranes and the increasing number of patents are also driving the adoption of filtration in the pharmaceutical and biotechnology industries.

The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10% and Middle East & Africa- 5%

List of Companies Profiled in the Report:
Thermo Fisher Scientific Inc. (US)
Merck KGaA (Germany)
Danaher Corporation (US)
Sartorius AG (Germany)
Thermo Fisher Scientific, Inc. (US)
3M Company (US)
Parker Hannifin Corporation (US)
Repligen Corporation (US)
Asahi Kasei Corporation (Japan)
Eaton Corporation plc (Ireland)
GEA Group (Germany)
Corning Incorporated (US)
Alfa Laval Corporate AB (Sweden)
Donaldson Company, Inc. (US)
Saint-Gobain (France)
MANN+HUMMEL International GmbH & Co. KG (Germany)
Meissner Filtration Products, Inc. (US)
Cole-Parmer Instrument Company, LLC (US)
Applexion (France)
Cantel Medical Corp. (US)
W. L. Gore & Associates Inc. (US)
Membrane Solutions (US)
Amazon Filters Ltd. (UK)
Toyo Roshi Kaisha, Ltd. (Japan)
Porvair plc (UK)
Sterlitech Corporation (US)
Synder Filtration, Inc. (US)
Graver Technologies, LLC (US)
Koch Membrane Systems, Inc. (US)
Nupore Filtration Systems (India)
Cobetter Filtration Equipment Co., Ltd. (China).

Research Coverage:
This research report categorizes the pharmaceutical membrane filtration market by product (membrane filters, systems, and other products), by technique (microfiltration, ultrafiltration, nanofiltration, and other techniques), by application (final product processing, raw material filtration, cell separation, water purification, and air purification), by type (sterile filtration and non-sterile filtration), by scale of operation (manufacturing scale operation, pilot scale operation, and R&D scale operation) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the pharmaceutical membrane filtration market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the pharmaceutical membrane filtration market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical membrane filtration market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:
• Analysis of key drivers (increasing adoption of single-use technologies, stringent regulatory requirements, rising R&D spending in pharmaceutical and biotechnology industries, and increasing purity requirements in end-use industries), restraints (membrane fouling issues and high capital investment requirements to limit entry of smaller players), opportunities (growing opportunities in emerging economies, advances in nanofiltration technology), and Challenges (increased cost and reduced speed & yield of filters) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the pharmaceutical membrane filtration market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical membrane filtration market
• Competitive Assessment: Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (US), 3M Company (US), Parker Hannifin Corporation (US), Repligen Corporation (US), Asahi Kasei Corporation (Japan), Eaton Corporation plc (Ireland), GEA Group (Germany), Corning Incorporated (US), Alfa Laval Corporate AB (Sweden), Donaldson Company, Inc. (US), among others in the market. 

Table of Contents

1            INTRODUCTION            68

1.1         STUDY OBJECTIVES      68

1.2         MARKET DEFINITION   68

1.2.1      INCLUSIONS AND EXCLUSIONS OF STUDY         69

1.3         STUDY SCOPE  70

1.3.1      MARKET SEGMENTATION         70

1.3.2      REGIONS COVERED      71

1.4         YEARS CONSIDERED     71

1.5         CURRENCY        72

1.6         STAKEHOLDERS            72

1.7         LIMITATIONS   72

1.8         SUMMARY OF CHANGES            73

1.9         RECESSION IMPACT      74

2            RESEARCH METHODOLOGY     75

2.1         RESEARCH DATA           75

FIGURE 1           RESEARCH DESIGN       75

2.1.1      SECONDARY DATA       76

2.1.2      PRIMARY DATA 77

FIGURE 2           BREAKDOWN OF PRIMARIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET  77

2.2         MARKET ESTIMATION METHODOLOGY            78

FIGURE 3           PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023     78

2.2.1      BOTTOM-UP APPROACH           78

FIGURE 4           MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023             79

FIGURE 5           REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF SARTORIUS AG (2023)   79

2.2.2      INSIGHTS FROM PRIMARY EXPERTS      81

FIGURE 6           MARKET SIZE VALIDATION FROM PRIMARY SOURCES  81

2.2.3      TOP-DOWN APPROACH             81

FIGURE 7           MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH       81

2.3         GROWTH FORECAST    82

FIGURE 8           PHARMACEUTICAL MEMBRANE FILTRATION MARKET: CAGR PROJECTIONS  83

2.4         MARKET BREAKDOWN AND DATA TRIANGULATION    84

FIGURE 9           DATA TRIANGULATION METHODOLOGY         84

2.5         RESEARCH ASSUMPTIONS         85

2.6         MARKET FORECAST      85

TABLE 1             FACTOR ANALYSIS        85

2.7         RISK ANALYSIS 86

2.8         RECESSION IMPACT ANALYSIS 86

3            EXECUTIVE SUMMARY 88

FIGURE 10         PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)            88

FIGURE 11         PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)        89

FIGURE 12         PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)     90

FIGURE 13         PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)       91

FIGURE 14         PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2024 VS. 2029 (USD MILLION)    91

FIGURE 15         GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL MEMBRANE FILTRATION MARKET        92

4            PREMIUM INSIGHTS      94

4.1         PHARMACEUTICAL MEMBRANE FILTRATION MARKET OVERVIEW              94

FIGURE 16         RISING R&D SPENDING IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES TO DRIVE MARKET GROWTH  94

4.2         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT AND COUNTRY (2023)  95

FIGURE 17         MEMBRANE FILTERS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL MEMBRANE FILTRATION MARKET IN 2023             95

4.3         PHARMACEUTICAL MEMBRANE FILTRATION MARKET SHARE, BY APPLICATION, 2024 VS. 2029      95

FIGURE 18         FINAL PRODUCT PROCESSING SEGMENT TO DOMINATE MARKET IN 2029             95

4.4         PHARMACEUTICAL MEMBRANE FILTRATION MARKET SHARE, BY TECHNIQUE, 2023          96

FIGURE 19         MICROFILTRATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 96

4.5         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES       97

FIGURE 20         ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE FROM 2024 TO 2029           97

5            MARKET OVERVIEW     98

5.1         INTRODUCTION            98

5.2         MARKET DYNAMICS     98

FIGURE 21         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    98

TABLE 2             PHARMACEUTICAL MEMBRANE FILTRATION MARKET: IMPACT ANALYSIS         99

5.2.1      DRIVERS            99

5.2.1.1   Increasing adoption of single-use technologies             99

5.2.1.2   Stringent regulatory requirements   100

5.2.1.3   Rising R&D spending in pharmaceutical and biotechnology industries     100

FIGURE 22         PHARMACEUTICAL R&D SPENDING, 2014–2028 (USD BILLION)              101

5.2.1.4   Increasing purity requirements in end-use industries   101

5.2.2      RESTRAINTS     102

5.2.2.1   Membrane fouling issues    102

5.2.2.2   High capital investment requirements to limit entry of smaller players     102

5.2.3      OPPORTUNITIES           103

5.2.3.1   Growth opportunities in emerging economies 103

5.2.3.2   Advances in nanofiltration technology           103

5.2.4      CHALLENGES   104

5.2.4.1   Increased cost and reduced speed & yield of filters       104

5.3         TECHNOLOGY ANALYSIS           104

TABLE 3             TECHNOLOGY ANALYSIS           104

5.4         SUPPLY CHAIN ANALYSIS          105

FIGURE 23         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: SUPPLY CHAIN ANALYSIS          105

5.5         VALUE CHAIN ANALYSIS            106

FIGURE 24         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: VALUE CHAIN ANALYSIS           107

5.6         ECOSYSTEM ANALYSIS 108

FIGURE 25         PHARMACEUTICAL MEMBRANE FILTRATION MARKET ECOSYSTEM     108

5.6.1      PHARMACEUTICAL MEMBRANE FILTRATION RAW MATERIAL SUPPLIERS        109

TABLE 4             PHARMACEUTICAL MEMBRANE FILTRATION RAW MATERIAL SUPPLIERS        109

5.6.2      PHARMACEUTICAL MEMBRANE FILTRATION VENDORS            109

TABLE 5             PHARMACEUTICAL MEMBRANE FILTRATION VENDORS              109

5.6.3      PHARMACEUTICAL MEMBRANE FILTRATION END USERS          110

TABLE 6             PHARMACEUTICAL MEMBRANE FILTRATION END USERS              110

5.6.4      PHARMACEUTICAL MEMBRANE FILTRATION REGULATORY BODIES              111

TABLE 7             PHARMACEUTICAL MEMBRANE FILTRATION REGULATORY BODIES 111

5.7         TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS     111

FIGURE 26         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: TRENDS/DISRUPTIONS IMPACTING CLIENT’S BUSINESS            111

5.8         PRICING ANALYSIS        113

TABLE 8             AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT              113

5.8.1      AVERAGE SELLING PRICE RANGE, BY REGION, 2023       113

TABLE 9             AVERAGE SELLING PRICE, BY REGION, 2023       113

5.9         REGULATORY LANDSCAPE       114

5.9.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          114

TABLE 10           NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         114

TABLE 11           EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 115

TABLE 12           ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         115

TABLE 13           LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         116

TABLE 14           MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         116

5.9.2      REGULATORY SCENARIO IN DIFFERENT COUNTRIES    117

5.10       PATENT ANALYSIS        118

5.10.1    METHODOLOGY           118

5.10.2    PATENTS FILED, BY DOCUMENT TYPE, 2013–2023          118

TABLE 15           PATENTS FILED, 2013–2023        118

5.10.3    INNOVATION AND PATENT APPLICATIONS      118

FIGURE 27         TOTAL NUMBER OF PATENTS GRANTED, 2014–2023      118

5.10.4    TOP APPLICANTS          119

FIGURE 28         TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2023         119

TABLE 16           TOP 20 PATENT OWNERS IN PHARMACEUTICAL MEMBRANE FILTRATION MARKET, 2014–2023            119

TABLE 17           PATENTS IN PHARMACEUTICAL MEMBRANE FILTRATION MARKET, 2023  120

5.11       INVESTMENT/FUNDING ACTIVITIES    121

5.12       KEY CONFERENCES AND EVENTS, 2024 122

TABLE 18           PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2024  122

5.13       PORTER’S FIVE FORCES ANALYSIS         123

TABLE 19           PHARMACEUTICAL MEMBRANE FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS         123

5.13.1    THREAT OF NEW ENTRANTS    123

5.13.2    THREAT OF SUBSTITUTES         123

5.13.3    BARGAINING POWER OF BUYERS           124

5.13.4    BARGAINING POWER OF SUPPLIERS     124

5.13.5    INTENSITY OF COMPETITIVE RIVALRY 124

5.14       KEY STAKEHOLDERS AND BUYING CRITERIA    125

5.14.1    KEY STAKEHOLDERS IN BUYING PROCESS         125

FIGURE 29         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PHARMACEUTICAL MEMBRANE FILTRATION PRODUCTS          125

5.14.2    KEY BUYING CRITERIA FOR PHARMACEUTICAL MEMBRANE FILTRATION PRODUCTS AMONG END USERS   125

FIGURE 30         KEY BUYING CRITERIA FOR END USERS              125

TABLE 20           BUYING CRITERIA FOR PHARMACEUTICAL MEMBRANE FILTRATION, BY END USER       126

5.15       CASE STUDY ANALYSIS 127

5.15.1    CASE STUDY 1: PELLICON 2 CASSETTE PROCESSING OF THERAPEUTIC PROTEINS         127

5.15.2    CASE STUDY 2: FILTER HOUSING CAPABLE OF HANDLING BOTH GAS AND LIQUID     127

5.15.3    CASE STUDY 3: 3M OFFERS EMPHAZE AEX HYBRID PURIFIER TO REDUCE IMPURITIES IN BIOPHARMACEUTICAL DOWNSTREAM PROCESS              127

5.15.4    CASE STUDY 4: DELIVERY OF POLYPROPYLENE PLEATED CARTRIDGES FOR HIGH-PURITY PHARMACEUTICAL PRODUCTS           128

5.15.5    CASE STUDY 5: USE OF POLYPROPYLENE HIGH-FLOW CARTRIDGE FOR FINAL FILTRATION PROCESS         128

6            PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT              129

6.1         INTRODUCTION            130

TABLE 21           PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   130

6.2         MEMBRANE FILTERS    130

TABLE 22           PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)          131

TABLE 23          PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)          132

TABLE 24           NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         132

TABLE 25           EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            133

TABLE 26           ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         133

TABLE 27           LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         134

TABLE 28           MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)            134

TABLE 29           GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         134

6.2.1      POLYETHERSULFONE MEMBRANE FILTERS      135

6.2.1.1   Wide use of hydrophilic PES membranes in sterilizing applications to drive growth              135

TABLE 30           POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)       135

TABLE 31           NORTH AMERICA: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         136

TABLE 32           EUROPE: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            136

TABLE 33           ASIA PACIFIC: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         137

TABLE 34           LATIN AMERICA: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         137

TABLE 35           MIDDLE EAST: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)            138

TABLE 36           GCC COUNTRIES: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         138

6.2.2      POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS   138

6.2.2.1   Non-toxic, highly pure, and biologically safe—advantages supporting market growth   138

TABLE 37          POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)  139

TABLE 38           NORTH AMERICA: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              139

TABLE 39           EUROPE: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         140

TABLE 40           ASIA PACIFIC: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       140

TABLE 41           LATIN AMERICA: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       141

TABLE 42           MIDDLE EAST: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)           141

TABLE 43           GCC COUNTRIES: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       141

6.2.3      NYLON MEMBRANE FILTERS    142

6.2.3.1   Increased endotoxin adsorption capacity to drive growth            142

TABLE 44           NYLON MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 142

TABLE 45           NORTH AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    142

TABLE 46           EUROPE: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          143

TABLE 47           ASIA PACIFIC: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    143

TABLE 48           LATIN AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    144

TABLE 49           MIDDLE EAST: NYLON MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)       144

TABLE 50           GCC COUNTRIES: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    144

6.2.4      POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS  145

6.2.4.1   PTFE membrane filters offer retention of ratings as fine as 0.01μ           145

TABLE 51           POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)            145

TABLE 52           NORTH AMERICA: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              145

TABLE 53           EUROPE: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       146

TABLE 54           ASIA PACIFIC: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       146

TABLE 55           LATIN AMERICA: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       147

TABLE 56           MIDDLE EAST: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)           147

TABLE 57           GCC COUNTRIES: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              147

6.2.5      MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS             148

6.2.5.1   Provide optically compatible surface for greater adsorption of products    148

TABLE 58           MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)   148

TABLE 59           NORTH AMERICA: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          149

TABLE 60           EUROPE: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              149

TABLE 61           ASIA PACIFIC: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          150

TABLE 62           LATIN AMERICA: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          150

TABLE 63           MIDDLE EAST: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)          151

TABLE 64           GCC COUNTRIES: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          151

6.2.6      POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS           151

6.2.6.1   Widely used in cell biology and analytical testing applications    151

TABLE 65           POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)            152

TABLE 66           NORTH AMERICA: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              152

TABLE 67           EUROPE: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       153

TABLE 68           ASIA PACIFIC: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       153

TABLE 69           LATIN AMERICA: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              154

TABLE 70           MIDDLE EAST: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)   154

TABLE 71           GCC COUNTRIES: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              154

6.2.7      OTHER MEMBRANE FILTERS    155

TABLE 72           OTHER MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 156

TABLE 73           NORTH AMERICA: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    156

TABLE 74           EUROPE: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          157

TABLE 75           ASIA PACIFIC: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    157

TABLE 76           LATIN AMERICA: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    158

TABLE 77           MIDDLE EAST: OTHER MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION)       158

TABLE 78           GCC COUNTRIES: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    158

6.3         SYSTEMS           159

TABLE 79           PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)    159

TABLE 80           PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)            160

TABLE 81           NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              160

TABLE 82           EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     161

TABLE 83           ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     161

TABLE 84           LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     162

TABLE 85           MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)         162

TABLE 86           GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              162

6.3.1      SINGLE-USE SYSTEMS  163

6.3.1.1   Reduced need for product validation and minimized cross-contamination risk to boost adoption     163

TABLE 87           SINGLE-USE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)          163

TABLE 88           NORTH AMERICA: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    164

TABLE 89           EUROPE: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     164

TABLE 90           ASIA PACIFIC: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          165

TABLE 91           LATIN AMERICA: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    165

TABLE 92           MIDDLE EAST: SINGLE-USE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)          165

TABLE 93           GCC COUNTRIES: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    166

6.3.2      REUSABLE SYSTEMS     166

6.3.2.1   Widely used for large-scale manufacturing     166

TABLE 94           REUSABLE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)          166

TABLE 95          NORTH AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          167

TABLE 96           EUROPE: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     167

TABLE 97           ASIA PACIFIC: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          168

TABLE 98           LATIN AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          168

TABLE 99           MIDDLE EAST: REUSABLE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)          168

TABLE 100         GCC COUNTRIES: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          169

6.4         OTHER PRODUCTS       169

TABLE 101         PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)             169

TABLE 102         PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY REGION, 2022–2029 (USD MILLION)        170

TABLE 103         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)          170

TABLE 104         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)              171

TABLE 105         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)              171

TABLE 106         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)              172

TABLE 107         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY REGION, 2022–2029 (USD MILLION)              172

TABLE 108         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION)          172

6.4.1      MEMBRANE FILTRATION ASSEMBLIES  173

6.4.1.1   Leading players provide pre-assembled filtration assemblies      173

TABLE 109         MEMBRANE FILTRATION ASSEMBLIES MARKET, BY REGION, 2022–2029 (USD MILLION)          173

TABLE 110         NORTH AMERICA: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         173

TABLE 111         EUROPE: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    174

TABLE 112         ASIA PACIFIC: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            174

TABLE 113         LATIN AMERICA: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         175

TABLE 114        MIDDLE EAST: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY REGION, 2022–2029 (USD MILLION)  175

TABLE 115         GCC COUNTRIES: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         175

6.4.2      ACCESSORIES   176

6.4.2.1   Increasing adoption of pharmaceutical membrane filtration products to support growth   176

TABLE 116         PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)            176

TABLE 117         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              176

TABLE 118         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)           177

TABLE 119         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)           177

TABLE 120         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)           178

TABLE 121         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 178

TABLE 122         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              178

7            PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE     179

7.1         INTRODUCTION            180

TABLE 123         PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 180

7.2         MICROFILTRATION      180

7.2.1      AVAILABILITY OF INNOVATIVE AND COST-EFFECTIVE MICROFILTRATION MEMBRANES TO SUPPORT MARKET GROWTH       180

TABLE 124         PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)  181

TABLE 125         NORTH AMERICA: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 181

TABLE 126         EUROPE: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         182

TABLE 127         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182

TABLE 128         LATIN AMERICA: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183

TABLE 129         MIDDLE EAST: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)    183

TABLE 130         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183

7.3         ULTRAFILTRATION      184

7.3.1      LEAST COSTLY TECHNIQUE TO OPERATE         184

TABLE 131         PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)  184

TABLE 132         NORTH AMERICA: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185

TABLE 133         EUROPE: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         185

TABLE 134         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186

TABLE 135         LATIN AMERICA: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186

TABLE 136         MIDDLE EAST: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)    187

TABLE 137         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 187

7.4         NANOFILTRATION        187

7.4.1      HIGH ENERGY CONSUMPTION TO HINDER MARKET GROWTH 187

TABLE 138         PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)  188

TABLE 139         NORTH AMERICA: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)  188

TABLE 140         EUROPE: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         189

TABLE 141         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)  189

TABLE 142         LATIN AMERICA: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)  190

TABLE 143         MIDDLE EAST: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)      190

TABLE 144         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)  190

7.5         OTHER TECHNIQUES   191

TABLE 145         PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY REGION, 2022–2029 (USD MILLION)    191

TABLE 146         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 191

TABLE 147         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)              192

TABLE 148         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)              192

TABLE 149         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)              193

TABLE 150         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY REGION, 2022–2029 (USD MILLION)              193

TABLE 151         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 193

8            PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION  194

8.1         INTRODUCTION            195

TABLE 152         PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           195

8.2         FINAL PRODUCT PROCESSING 195

TABLE 153         PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)       196

TABLE 154         PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2022–2029 (USD MILLION) 196

TABLE 155         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION)     197

TABLE 156         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION)          197

TABLE 157         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION)          198

TABLE 158         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION)          198

TABLE 159         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2022–2029 (USD MILLION)          199

TABLE 160         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION)     199

8.2.1      ACTIVE PHARMACEUTICAL INGREDIENT (API) FILTRATION     199

8.2.1.1   Continuous requirement for API filtration to drive market         199

TABLE 161         ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)            200

TABLE 162         NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             200

TABLE 163         EUROPE: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             201

TABLE 164         ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             201

TABLE 165         LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             202

TABLE 166         MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)   202

TABLE 167         GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             202

8.2.2      PROTEIN PURIFICATION            203

8.2.2.1   Advancements in protein therapeutic drugs to propel growth     203

TABLE 168         PROTEIN PURIFICATION MARKET, BY REGION, 2022–2029 (USD MILLION)          203

TABLE 169         NORTH AMERICA: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    204

TABLE 170         EUROPE: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          204

TABLE 171         ASIA PACIFIC: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    205

TABLE 172         LATIN AMERICA: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    205

TABLE 173         MIDDLE EAST: PROTEIN PURIFICATION MARKET, BY REGION, 2022–2029 (USD MILLION)          205

TABLE 174         GCC COUNTRIES: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    206

8.2.3      VACCINE AND ANTIBODY PROCESSING             206

8.2.3.1   Rising investments in life science R&D to drive growth              206

TABLE 175         VACCINE AND ANTIBODY PROCESSING MARKET, BY REGION, 2022–2029 (USD MILLION)          206

TABLE 176         NORTH AMERICA: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         207

TABLE 177         EUROPE: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    207

TABLE 178         ASIA PACIFIC: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         208

TABLE 179         LATIN AMERICA: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         208

TABLE 180         MIDDLE EAST: VACCINE AND ANTIBODY PROCESSING MARKET, BY REGION, 2022–2029 (USD MILLION)            209

TABLE 181         GCC COUNTRIES: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         209

8.2.4      FORMULATION AND FILLING SOLUTIONS        209

8.2.4.1   Demand for aseptic filling and bioburden reduction to propel growth      209

TABLE 182         FORMULATION AND FILLING SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION)       210

TABLE 183         NORTH AMERICA: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         210

TABLE 184         EUROPE: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            211

TABLE 185         ASIA PACIFIC: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         211

TABLE 186         LATIN AMERICA: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         212

TABLE 187         MIDDLE EAST: FORMULATION AND FILLING SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION)            212

TABLE 188         GCC COUNTRIES: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         212

8.2.5      VIRAL CLEARANCE        213

8.2.5.1   Development of therapeutic monoclonal antibodies to drive market         213

TABLE 189         VIRAL CLEARANCE MARKET, BY REGION, 2022–2029 (USD MILLION)          213

TABLE 190         NORTH AMERICA: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          214

TABLE 191         EUROPE: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 214

TABLE 192         ASIA PACIFIC: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          215

TABLE 193         LATIN AMERICA: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          215

TABLE 194         MIDDLE EAST: VIRAL CLEARANCE MARKET, BY REGION, 2022–2029 (USD MILLION)     215

TABLE 195         GCC COUNTRIES: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          216

8.3         RAW MATERIAL FILTRATION    216

TABLE 196         PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)         216

TABLE 197         PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2022–2029 (USD MILLION)    217

TABLE 198         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION)     217

TABLE 199         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION)          218

TABLE 200         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION)          218

TABLE 201         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION)          219

TABLE 202         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2022–2029 (USD MILLION)          219

TABLE 203         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022–2029 (USD MILLION)     219

8.3.1      MEDIA AND BUFFER FILTRATION          220

8.3.1.1   Growth in manufacturing of biopharmaceuticals to drive market              220

TABLE 204         MEDIA AND BUFFER FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)     220

TABLE 205         NORTH AMERICA: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            221

TABLE 206         EUROPE: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    221

TABLE 207         ASIA PACIFIC: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    222

TABLE 208         LATIN AMERICA: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            222

TABLE 209         MIDDLE EAST: MEDIA AND BUFFER FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)       223

TABLE 210         GCC COUNTRIES: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            223

8.3.2      PREFILTRATION            223

8.3.2.1   Membrane fouling issues to support market growth     223

TABLE 211         PREFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)          224

TABLE 212         NORTH AMERICA: PREFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          224

TABLE 213         EUROPE: PREFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 225

TABLE 214         ASIA PACIFIC: PREFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     225

TABLE 215         LATIN AMERICA: PREFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          226

TABLE 216         MIDDLE EAST: PREFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)     226

TABLE 217         GCC COUNTRIES: PREFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          226

8.3.3      BIOBURDEN TESTING  227

8.3.3.1   Strict quality control of biopharmaceuticals to propel growth     227

TABLE 218         BIOBURDEN TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)          227

TABLE 219         NORTH AMERICA: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    227

TABLE 220         EUROPE: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     228

TABLE 221         ASIA PACIFIC: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          228

TABLE 222         LATIN AMERICA: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    229

TABLE 223         MIDDLE EAST: BIOBURDEN TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)          229

TABLE 224         GCC COUNTRIES: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    229

8.4         CELL SEPARATION        230

8.4.1      GROWTH IN PERSONALIZED MEDICINE TO PROPEL MARKET  230

TABLE 225         PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY REGION, 2022–2029 (USD MILLION)        230

TABLE 226         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022–2029 (USD MILLION)          230

TABLE 227         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022–2029 (USD MILLION)              231

TABLE 228         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022–2029 (USD MILLION)              231

TABLE 229         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022–2029 (USD MILLION)              232

TABLE 230         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY REGION, 2022–2029 (USD MILLION)              232

TABLE 231         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022–2029 (USD MILLION)          232

8.5         WATER PURIFICATION 233

8.5.1      INCREASING DEMAND FOR PURIFIED WATER FROM HOSPITALS TO DRIVE MARKET 233

TABLE 232         PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY REGION, 2022–2029 (USD MILLION) 233

TABLE 233         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 233

TABLE 234         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION)              234

TABLE 235         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION)              234

TABLE 236         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION)              235

TABLE 237         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY REGION, 2022–2029 (USD MILLION)              235

TABLE 238         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION) 235

8.6         AIR PURIFICATION        236

8.6.1      INCREASING ADOPTION OF GMP PRACTICES TO SUPPORT MARKET GROWTH          236

TABLE 239         PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2022–2029 (USD MILLION)        236

TABLE 240         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION)          237

TABLE 241         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION)              237

TABLE 242         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION)              238

TABLE 243         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION)              238

TABLE 244         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2022–2029 (USD MILLION)              238

TABLE 245         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022–2029 (USD MILLION)          239

9            PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE              240

9.1         INTRODUCTION            241

TABLE 246         PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             241

9.2         STERILE FILTRATION   241

9.2.1      GROWING DEMAND FOR BIOLOGICS DRUGS TO DRIVE DEMAND              241

TABLE 247         PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)            242

TABLE 248         NORTH AMERICA: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             242

TABLE 249         EUROPE: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             243

TABLE 250         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             243

TABLE 251         LATIN AMERICA: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             244

TABLE 252         MIDDLE EAST: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)   244

TABLE 253         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             244

9.3         NON-STERILE FILTRATION       245

9.3.1      GROWTH IN PHARMA R&D ACTIVITIES TO PROPEL MARKET    245

TABLE 254         PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)            245

TABLE 255         NORTH AMERICA: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              245

TABLE 256         EUROPE: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             246

TABLE 257         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             246

TABLE 258         LATIN AMERICA: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              247

TABLE 259         MIDDLE EAST: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)   247

TABLE 260         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              247

10          PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION      248

10.1       INTRODUCTION            249

TABLE 261         PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)          249

10.2       MANUFACTURING SCALE          249

10.2.1    GROWTH IN MANUFACTURING OF BIOLOGICS AND BIOSIMILARS TO DRIVE MARKET 249

TABLE 262         MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)   250

TABLE 263         NORTH AMERICA: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     251

TABLE 264         EUROPE: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              251

TABLE 265         ASIA PACIFIC: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              252

TABLE 266         LATIN AMERICA: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     252

TABLE 267         MIDDLE EAST: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)              253

TABLE 268         GCC COUNTRIES: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     253

10.3       PILOT SCALE    253

10.3.1    INCREASED OUTSOURCING TO DRIVE MARKET GROWTH         253

TABLE 269         PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)            254

TABLE 270         NORTH AMERICA: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              254

TABLE 271         EUROPE: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             255

TABLE 272         ASIA PACIFIC: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             255

TABLE 273         LATIN AMERICA: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              256

TABLE 274         MIDDLE EAST: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)   256

TABLE 275         GCC COUNTRIES: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              256

10.4       R&D SCALE       257

10.4.1    INCREASING INVESTMENTS IN R&D OF BIOLOGICS TO PROPEL GROWTH          257

TABLE 276         R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)            257

TABLE 277         NORTH AMERICA: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              258

TABLE 278         EUROPE: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             258

TABLE 279         ASIA PACIFIC: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             259

TABLE 280         LATIN AMERICA: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             259

TABLE 281         MIDDLE EAST: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)   260

TABLE 282         GCC COUNTRIES: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             260

11          PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION              261

11.1       INTRODUCTION            262

TABLE 283         PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)       262

11.2       NORTH AMERICA          262

FIGURE 31         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SNAPSHOT         263

TABLE 284         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             264

TABLE 285         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)             264

TABLE 286         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)    265

TABLE 287         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     265

TABLE 288         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)          266

TABLE 289         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)         266

TABLE 290         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)      267

TABLE 291         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 267

TABLE 292         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 268

TABLE 293         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)        268

TABLE 294         NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)              268

11.2.1    US         269

11.2.1.1 Technological advancements in filtration membranes to support market growth              269

TABLE 295         US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   269

TABLE 296         US: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             270

TABLE 297         US: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)    270

TABLE 298         US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)    271

TABLE 299         US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 271

TABLE 300         US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           272

TABLE 301         US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)              272

TABLE 302         US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 273

TABLE 303         US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             273

TABLE 304         US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)          273

11.2.2    CANADA            274

11.2.2.1 Growing government support for expanding manufacturing facilities to drive market   274

TABLE 305         CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        274

TABLE 306         CANADA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)       275

TABLE 307         CANADA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 275

TABLE 308         CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)  276

TABLE 309         CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)     276

TABLE 310         CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  277

TABLE 311         CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)          277

TABLE 312         CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)          278

TABLE 313         CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    278

TABLE 314         CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 278

11.2.3    NORTH AMERICA: RECESSION IMPACT 279

11.3       EUROPE             279

TABLE 315         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         280

TABLE 316         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        280

TABLE 317         EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)       281

TABLE 318         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 281

TABLE 319         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)  282

TABLE 320         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)     282

TABLE 321         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  283

TABLE 322         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)          283

TABLE 323         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)          284

TABLE 324         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    284

TABLE 325         EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 284

11.3.1    GERMANY         285

11.3.1.1 Growing pharmaceutical R&D and manufacturing to drive market           285

TABLE 326         GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        285

TABLE 327         GERMANY: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)       286

TABLE 328         GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 286

TABLE 329         GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)  287

TABLE 330         GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)     287

TABLE 331         GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  288

TABLE 332         GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)          288

TABLE 333         GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)          289

TABLE 334         GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    289

TABLE 335         GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 289

11.3.2    UK         290

11.3.2.1 Increased R&D investments and government aid to boost market growth 290

TABLE 336         UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)   290

TABLE 337         UK: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             291

TABLE 338         UK: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)    291

TABLE 339         UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)    292

TABLE 340         UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 292

TABLE 341         UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           293

TABLE 342         UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)              293

TABLE 343         UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 294

TABLE 344         UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             294

TABLE 345         UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)          294

11.3.3    FRANCE             295

11.3.3.1 Increasing government investments in pharmaceutical industry to drive growth              295

TABLE 346         FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        295

TABLE 347         FRANCE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)       296

TABLE 348         FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 296

TABLE 349         FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)  297

TABLE 350         FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)     297

TABLE 351         FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  298

TABLE 352         FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)          298

TABLE 353         FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)          299

TABLE 354         FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    299

TABLE 355         FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 299

11.3.4    ITALY   300

11.3.4.1 Rising research activities in pharma R&D to boost market growth            300

TABLE 356         ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            300

TABLE 357         ITALY: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             301

TABLE 358         ITALY: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)    301

TABLE 359         ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)    302

TABLE 360         ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)        302

TABLE 361         ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     303

TABLE 362         ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)              303

TABLE 363         ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 304

TABLE 364         ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)       304

TABLE 365         ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)    304

11.3.5    SPAIN   305

11.3.5.1 Expansion of biomanufacturing facilities to support market growth          305

TABLE 366         SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            305

TABLE 367         SPAIN: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             306

TABLE 368         SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)    306

TABLE 369         SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)    307

TABLE 370         SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)        307

TABLE 371         SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     308

TABLE 372         SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)              308

TABLE 373         SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 309

TABLE 374         SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)       309

TABLE 375         SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)    309

11.3.6    REST OF EUROPE           310

TABLE 376         REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)             310

TABLE 377         REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)    311

TABLE 378         REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     311

TABLE 379         REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)          312

TABLE 380         REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)         312

TABLE 381         REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)      313

TABLE 382         REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 313

TABLE 383         REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 314

TABLE 384         REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)        314

TABLE 385         REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)              314

11.3.7    EUROPE: RECESSION IMPACT   315

11.4       ASIA PACIFIC    315

FIGURE 32         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SNAPSHOT     316

TABLE 386         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         317

TABLE 387         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        317

TABLE 388         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)    318

TABLE 389         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 318

TABLE 390         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)  319

TABLE 391         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)     319

TABLE 392         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  320

TABLE 393         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)          320

TABLE 394         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)          321

TABLE 395         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    321

TABLE 396         ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 321

11.4.1    CHINA  322

11.4.1.1 China to dominate Asia Pacific market during forecast period    322

TABLE 397        CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            322

TABLE 398         CHINA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             323

TABLE 399         CHINA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)    323

TABLE 400         CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)    324

TABLE 401        CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)        324

TABLE 402        CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     325

TABLE 403         CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)              325

TABLE 404         CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 326

TABLE 405        CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)       326

TABLE 406        CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)    326

11.4.2    JAPAN  327

11.4.2.1 Stringent regulatory guidelines to increase demand for advanced filtration products 327

TABLE 407         JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            327

TABLE 408         JAPAN: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             328

TABLE 409         JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)    328

TABLE 410         JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)    329

TABLE 411         JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)        329

TABLE 412         JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     330

TABLE 413         JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)              330

TABLE 414         JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 331

TABLE 415         JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)       331

TABLE 416         JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)    331

11.4.3    INDIA   332

11.4.3.1 Government initiatives to favor market growth            332

TABLE 417         INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            332

TABLE 418         INDIA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             333

TABLE 419         INDIA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)    333

TABLE 420         INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)    334

TABLE 421         INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)        334

TABLE 422         INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     335

TABLE 423         INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)              335

TABLE 424         INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 336

TABLE 425         INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)       336

TABLE 426         INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)    336

11.4.4    SOUTH KOREA 337

11.4.4.1 Increased export of drugs to support market growth     337

TABLE 427         SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        337

TABLE 428         SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)    338

TABLE 429         SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 338

TABLE 430         SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)  339

TABLE 431         SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)     339

TABLE 432         SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  340

TABLE 433         SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)          340

TABLE 434         SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)          341

TABLE 435         SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    341

TABLE 436         SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 341

11.4.5    AUSTRALIA       342

11.4.5.1 Increasing demand for innovative filtration solutions to propel market     342

TABLE 437         AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        342

TABLE 438        AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)       343

TABLE 439         AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 343

TABLE 440         AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)  344

TABLE 441         AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)     344

TABLE 442         AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  345

TABLE 443         AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)          345

TABLE 444         AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)          346

TABLE 445         AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    346

TABLE 446         AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 346

11.4.6    REST OF ASIA PACIFIC  347

TABLE 447         REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)             347

TABLE 448         REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)  348

TABLE 449         REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     348

TABLE 450         REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)          349

TABLE 451         REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)         349

TABLE 452         REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)      350

TABLE 453         REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 350

TABLE 454         REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 351

TABLE 455         REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)        351

TABLE 456         REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)              351

11.4.7    ASIA PACIFIC: RECESSION IMPACT        352

11.5       LATIN AMERICA             353

TABLE 457         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         353

TABLE 458         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        353

TABLE 459         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)    354

TABLE 460         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 354

TABLE 461         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)  355

TABLE 462         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)     355

TABLE 463         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  356

TABLE 464         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)          356

TABLE 465         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)          357

TABLE 466         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    357

TABLE 467         LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 357

11.5.1    BRAZIL 358

11.5.1.1 Growth of vaccine manufacturing to drive market        358

TABLE 468         BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        358

TABLE 469         BRAZIL: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             359

TABLE 470         BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 359

TABLE 471         BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)  360

TABLE 472         BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)     360

TABLE 473         BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  361

TABLE 474         BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)          361

TABLE 475         BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)          362

TABLE 476         BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    362

TABLE 477         BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 362

11.5.2    MEXICO             363

11.5.2.1 Rising demand for chronic disease treatment to support market growth   363

TABLE 478         MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        363

TABLE 479         MEXICO: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)       364

TABLE 480         MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 364

TABLE 481         MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)  365

TABLE 482         MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)     365

TABLE 483         MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  366

TABLE 484         MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)          366

TABLE 485         MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)          367

TABLE 486         MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    367

TABLE 487         MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 367

11.5.3    REST OF LATIN AMERICA          368

TABLE 488         REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)             368

TABLE 489         REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)  368

TABLE 490         REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     369

TABLE 491         REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)          369

TABLE 492         REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)         369

TABLE 493         REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)      370

TABLE 494         REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 370

TABLE 495         REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 371

TABLE 496         REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)        371

TABLE 497         REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)              371

11.5.4    LATIN AMERICA: RECESSION IMPACT   372

11.6       MIDDLE EAST  372

TABLE 498         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION)            372

TABLE 499         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        373

TABLE 500         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)    373

TABLE 501         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 374

TABLE 502         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)  374

TABLE 503         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)     374

TABLE 504         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  375

TABLE 505         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)          375

TABLE 506         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)          376

TABLE 507         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    376

TABLE 508         MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 376

11.6.1    GCC COUNTRIES           377

TABLE 509         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)             377

TABLE 510         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)             377

TABLE 511         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)    378

TABLE 512         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     378

TABLE 513         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)          379

TABLE 514         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)         379

TABLE 515         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)      380

TABLE 516         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 380

TABLE 517         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 381

TABLE 518         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)        381

TABLE 519         GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)              381

11.6.1.1 Saudi Arabia        382

11.6.1.1.1            Growing healthcare expenditure to boost market growth            382

TABLE 520         SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        382

TABLE 521         SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)    383

TABLE 522         SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 383

TABLE 523         SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)  384

TABLE 524         SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)     384

TABLE 525         SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  385

TABLE 526         SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)          385

TABLE 527         SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)          386

TABLE 528         SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    386

TABLE 529         SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 386

11.6.1.2 UAE      387

11.6.1.2.1            Rapidly growing pharmaceutical industry to aid market growth  387

TABLE 530         UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            387

TABLE 531         UAE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             388

TABLE 532         UAE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)    388

TABLE 533         UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)    389

TABLE 534         UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)        389

TABLE 535         UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     390

TABLE 536         UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)              390

TABLE 537         UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 391

TABLE 538         UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)       391

TABLE 539         UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)    391

11.6.1.3 Rest of GCC countries       392

TABLE 540         REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)             392

TABLE 541         REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)  392

TABLE 542         REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     393

TABLE 543         REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)          393

TABLE 544         REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)         393

TABLE 545         REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)      394

TABLE 546         REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 394

TABLE 547         REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 395

TABLE 548         REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)        395

TABLE 549         REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)              395

11.6.2    REST OF MIDDLE EAST 396

TABLE 550         REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)             396

TABLE 551         REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)  396

TABLE 552         REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     397

TABLE 553         REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)          397

TABLE 554         REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)         397

TABLE 555         REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)      398

TABLE 556         REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 398

TABLE 557         REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION) 399

TABLE 558         REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)        399

TABLE 559         REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION)              399

11.6.3    MIDDLE EAST: RECESSION IMPACT       400

11.7       AFRICA 400

11.7.1    GROWING MARKET FOR PHARMACEUTICALS AND INCREASING DEMAND FOR DRUGS TO PROPEL MARKET      400

TABLE 560         AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        400

TABLE 561         AFRICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)             401

TABLE 562         AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 401

TABLE 563         AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)  402

TABLE 564         AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)     402

TABLE 565         AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  403

TABLE 566         AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION)          403

TABLE 567         AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022–2029 (USD MILLION)          404

TABLE 568         AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    404

TABLE 569         AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022–2029 (USD MILLION) 404

11.7.2    AFRICA: RECESSION IMPACT     405

12          COMPETITIVE LANDSCAPE       406

12.1       INTRODUCTION            406

12.2       STRATEGIES ADOPTED BY KEY PLAYERS           406

TABLE 570         STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL MEMBRANE FILTRATION MARKET, 2022−2024        406

12.3       REVENUE SHARE ANALYSIS       407

FIGURE 33         REVENUE ANALYSIS OF KEY PLAYERS, 2019–2023 (USD MILLION)          407

12.4       MARKET SHARE ANALYSIS         408

FIGURE 34         MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)        408

TABLE 571         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DEGREE OF COMPETITION       409

12.5       COMPANY EVALUATION MATRIX: KEY PLAYERS            410

12.5.1    STARS  410

12.5.2    EMERGING LEADERS    410

12.5.3    PERVASIVE PLAYERS     410

12.5.4    PARTICIPANTS 411

FIGURE 35         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 411

12.6       COMPETITIVE BENCHMARKING OF KEY PLAYERS         412

12.6.1    COMPANY FOOTPRINT 412

FIGURE 36         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: COMPANY FOOTPRINT 412

12.6.2    PRODUCT FOOTPRINT 413

TABLE 572         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: PRODUCT FOOTPRINT 413

12.6.3    SCALE OF OPERATION FOOTPRINT      414

TABLE 573         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: SCALE OF OPERATION FOOTPRINT     414

12.6.4    REGIONAL FOOTPRINT             415

TABLE 574         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: REGIONAL FOOTPRINT             415

12.7       COMPANY EVALUATION MATRIX: STARTUPS/SMES      416

12.7.1    PROGRESSIVE COMPANIES       416

12.7.2    STARTING BLOCKS       416

12.7.3    RESPONSIVE COMPANIES          416

12.7.4    DYNAMIC COMPANIES 416

FIGURE 37         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023        417

12.8       COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS    418

TABLE 575         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS            418

TABLE 576         PHARMACEUTICAL MEMBRANE FILTRATION: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES        419

12.9       VALUATION AND FINANCIAL METRICS OF PHARMACEUTICAL MEMBRANE FILTRATION VENDORS      420

FIGURE 38         EV/EBITDA OF KEY VENDORS   420

FIGURE 39         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 420

12.10     BRAND/PRODUCT COMPARATIVE ANALYSIS    421

12.10.1  BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT      421

FIGURE 40         BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT              421

12.11     COMPETITIVE SCENARIO          422

12.11.1  PRODUCT LAUNCHES  422

TABLE 577         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2024    422

12.11.2  DEALS  422

TABLE 578         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DEALS, JANUARY 2021–JANUARY 2024   422

12.11.3  EXPANSIONS    423

TABLE 579         PHARMACEUTICAL MEMBRANE FILTRATION MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2024      423

13          COMPANY PROFILES    425

13.1       KEY PLAYERS   425

(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*

13.1.1    MERCK KGAA   425

TABLE 580         MERCK KGAA: BUSINESS OVERVIEW     425

FIGURE 41         MERCK KGAA: COMPANY SNAPSHOT (2022)      426

TABLE 581         MERCK KGAA: PRODUCTS OFFERED     426

TABLE 582         MERCK KGAA: DEALS   427

TABLE 583         MERCK KGAA: OTHER DEVELOPMENTS             428

13.1.2    DANAHER CORPORATION         430

TABLE 584         DANAHER CORPORATION: BUSINESS OVERVIEW           430

FIGURE 42         DANAHER CORPORATION: COMPANY SNAPSHOT (2022)              431

TABLE 585         DANAHER CORPORATION: PRODUCTS OFFERED          431

TABLE 586         DANAHER CORPORATION: DEALS         433

TABLE 587         DANAHER CORPORATION: EXPANSIONS           434

13.1.3    SARTORIUS AG 436

TABLE 588         SARTORIUS AG: BUSINESS OVERVIEW   436

FIGURE 43         SARTORIUS AG: COMPANY SNAPSHOT (2022)   437

TABLE 589         SARTORIUS AG: PRODUCTS OFFERED  437

TABLE 590         SARTORIUS AG: PRODUCT LAUNCHES 438

TABLE 591         SARTORIUS AG: DEALS 439

TABLE 592         SARTORIUS AG: EXPANSIONS   439

13.1.4    THERMO FISHER SCIENTIFIC INC.          441

TABLE 593         THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW              441

FIGURE 44         THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)   442

TABLE 594         THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED              442

TABLE 595         THERMO FISHER SCIENTIFIC INC.: DEALS          443

TABLE 596         THERMO FISHER SCIENTIFIC INC.: EXPANSIONS            444

13.1.5    3M COMPANY   445

TABLE 597         3M COMPANY: BUSINESS OVERVIEW     445

FIGURE 45         3M COMPANY: COMPANY SNAPSHOT (2022)     446

TABLE 598         3M COMPANY: PRODUCTS OFFERED    446

TABLE 599         3M COMPANY: EXPANSIONS     447

13.1.6    PARKER HANNIFIN CORPORATION       448

TABLE 600         PARKER HANNIFIN CORPORATION: BUSINESS OVERVIEW              448

FIGURE 46         PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2023)   449

TABLE 601         PARKER HANNIFIN CORPORATION: PRODUCTS OFFERED              449

TABLE 602         PARKER HANNIFIN CORPORATION: PRODUCT LAUNCHES              450

TABLE 603         PARKER HANNIFIN CORPORATION: DEALS       450

TABLE 604         PARKER HANNIFIN CORPORATION: EXPANSIONS          450

13.1.7    REPLIGEN CORPORATION        451

TABLE 605         REPLIGEN CORPORATION: BUSINESS OVERVIEW           451

FIGURE 47         REPLIGEN CORPORATION: COMPANY SNAPSHOT (2022)              452

TABLE 606         REPLIGEN CORPORATION: PRODUCTS OFFERED          452

TABLE 607         REPLIGEN CORPORATION: PRODUCT LAUNCHES         453

TABLE 608         REPLIGEN CORPORATION: DEALS         454

TABLE 609         REPLIGEN CORPORATION: EXPANSIONS           454

13.1.8    ASAHI KASEI CORPORATION     455

TABLE 610         ASAHI KASEI CORPORATION: BUSINESS OVERVIEW       455

FIGURE 48         ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022)              456

TABLE 611         ASAHI KASEI CORPORATION: PRODUCTS OFFERED      456

TABLE 612         ASAHI KASEI CORPORATION: EXPANSIONS       457

13.1.9    EATON CORPORATION PLC      458

TABLE 613         EATON CORPORATION PLC: BUSINESS OVERVIEW        458

FIGURE 49         EATON CORPORATION PLC: COMPANY SNAPSHOT (2022)              459

TABLE 614         EATON CORPORATION PLC: PRODUCTS OFFERED       459

TABLE 615         EATON CORPORATION PLC: PRODUCT LAUNCHES      460

13.1.10  GEA GROUP      461

TABLE 616         GEA GROUP: BUSINESS OVERVIEW        461

FIGURE 50         GEA GROUP: COMPANY SNAPSHOT (2022)        462

TABLE 617         GEA GROUP: PRODUCTS OFFERED       463

TABLE 618         GEA GROUP: PRODUCT LAUNCHES      463

13.1.11  CORNING INCORPORATED       464

TABLE 619         CORNING INCORPORATED: BUSINESS OVERVIEW         464

FIGURE 51         CORNING INCORPORATED: COMPANY SNAPSHOT (2022)              465

TABLE 620         CORNING INCORPORATED: PRODUCTS OFFERED         465

13.1.12  ALFA LAVAL CORPORATE AB    467

TABLE 621         ALFA LAVAL CORPORATE AB: BUSINESS OVERVIEW      467

FIGURE 52         ALFA LAVAL CORPORATE AB: COMPANY SNAPSHOT (2022)              468

TABLE 622         ALFA LAVAL CORPORATE AB: PRODUCTS OFFERED     468

13.1.13  DONALDSON COMPANY, INC.  470

TABLE 623         DONALDSON COMPANY, INC.: BUSINESS OVERVIEW    470

FIGURE 53         DONALDSON COMPANY, INC.: COMPANY SNAPSHOT (2023)              471

TABLE 624         DONALDSON COMPANY, INC.: PRODUCTS OFFERED    471

TABLE 625         DONALDSON COMPANY, INC.: PRODUCT LAUNCHES   472

TABLE 626         DONALDSON COMPANY, INC.: DEALS  472

TABLE 627         DONALDSON COMPANY, INC.: EXPANSIONS     473

13.1.14  SAINT-GOBAIN 474

TABLE 628         SAINT-GOBAIN: BUSINESS OVERVIEW  474

FIGURE 54         SAINT-GOBAIN: COMPANY SNAPSHOT (2022)   474

TABLE 629         SAINT-GOBAIN: PRODUCTS OFFERED  475

13.1.15  MANN+HUMMEL INTERNATIONAL GMBH & CO. KG      476

TABLE 630         MANN+HUMMEL INTERNATIONAL GMBH & CO. KG: BUSINESS OVERVIEW        476

FIGURE 55         MANN+HUMMEL INTERNATIONAL GMBH & CO. KG: COMPANY SNAPSHOT (2022)    477

TABLE 631         MANN+HUMMEL INTERNATIONAL GMBH & CO. KG: PRODUCTS OFFERED   477

13.1.16  MEISSNER FILTRATION PRODUCTS, INC.           478

TABLE 632         MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW        478

TABLE 633         MEISSNER FILTRATION PRODUCTS, INC.: PRODUCTS OFFERED          478

TABLE 634         MEISSNER FILTRATION PRODUCTS, INC.: EXPANSIONS 479

13.1.17  COLE-PARMER INSTRUMENT COMPANY, LLC   480

TABLE 635         COLE-PARMER INSTRUMENT COMPANY, LLC.: BUSINESS OVERVIEW        480

TABLE 636         COLE-PARMER INSTRUMENT COMPANY, LLC.: PRODUCTS OFFERED          480

13.1.18  APPLEXION      481

TABLE 637         APPLEXION: BUSINESS OVERVIEW         481

TABLE 638         APPLEXION: PRODUCTS OFFERED        481

13.1.19  CANTEL MEDICAL CORP.           482

TABLE 639         CANTEL MEDICAL CORP.: BUSINESS OVERVIEW             482

TABLE 640         CANTEL MEDICAL CORP.: PRODUCTS OFFERED            482

13.1.20  W. L. GORE & ASSOCIATES, INC.              483

TABLE 641         W. L. GORE & ASSOCIATES, INC.: BUSINESS OVERVIEW 483

TABLE 642         W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED 483

*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

13.2       OTHER PLAYERS           484

13.2.1    MEMBRANE SOLUTIONS            484

TABLE 643         MEMBRANE SOLUTIONS: BUSINESS OVERVIEW 484

13.2.2    AMAZON FILTERS LTD. 485

TABLE 644         AMAZON FILTERS LTD.: BUSINESS OVERVIEW  485

13.2.3    TOYO ROSHI KAISHA, LTD.       486

TABLE 645         TOYO ROSHI KAISHA, LTD.: BUSINESS OVERVIEW         486

13.2.4    PORVAIR PLC   487

TABLE 646         PORVAIR PLC: BUSINESS OVERVIEW     487

13.2.5    STERLITECH CORPORATION    488

TABLE 647         STERLITECH CORPORATION: BUSINESS OVERVIEW      488

13.2.6    SYNDER FILTRATION, INC.        489

TABLE 648         SYNDER FILTRATION, INC.: BUSINESS OVERVIEW          489

13.2.7    GRAVER TECHNOLOGIES, LLC 490

TABLE 649         GRAVER TECHNOLOGIES, LLC: BUSINESS OVERVIEW   490

13.2.8    KOCH MEMBRANE SYSTEMS, INC.          491

TABLE 650         KOCH MEMBRANE SYSTEMS, INC.: BUSINESS OVERVIEW              491

13.2.9    NUPORE FILTRATION SYSTEMS             492

TABLE 651         NUPORE FILTRATION SYSTEMS: BUSINESS OVERVIEW 492

13.2.10  COBETTER FILTRATION EQUIPMENT CO., LTD.             492

TABLE 652         COBETTER FILTRATION EQUIPMENT CO., LTD.: BUSINESS OVERVIEW        492

14          APPENDIX         493

14.1       DISCUSSION GUIDE      493

14.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             498

14.3       CUSTOMIZATION OPTIONS      500

14.4       RELATED REPORTS       501

14.5       AUTHOR DETAILS         502